19851-1-AP), anti-IL-6(cat
Furthermore, increased healthcare expenditure, demand for innovative therapies, growing awareness for early detection and diagnosis, supportive government initiatives and regulatory frameworks, access to expert healthcare professionals and, the proven efficacy and safety of GLP-1 receptor agonists for managing blood sugar and promoting weight loss are the factors fuelling the market dominance of this segment
Failure of autophagy in this context promotes the accumulation of oxidative stress, aberrant signaling, mitochondrial damage, and chronic inflammation, collectively establishing a pro-tumorigenic cellular environment
For patients, this translates to less tissue disruption, reduced post-operative pain and a much smoother rehabilitation process
10.1177/1756284821993586 Therap Adv Gastroenterol